RECODE · 연구동향생성일 2026-10-31

연구동향

기준 논문: Polymorphisms of small ubiquitin-related modifier genes are associated with risk of Alzheimer's disease in Korean: A case-control study

J Neurol Sci 364:122-127 · 2016 · PMID 27084229

검색 방법

이 논문의 제목과 주제어를 바탕으로 이 논문이 속한 연구 분야를 묻는 질문을 만들어 ReviewFast에 넣어 2026-10-31에 검색했습니다. ReviewFast가 PubMed를 검색하고, AI 모델(Jev)이 제목과 초록을 읽어 질문과의 관련도를 매긴 뒤 주제별로 묶었습니다.

163편 검색→157편 판독→70편 선별 (관련도 0.5 이상)

질문과 PubMed 검색식 보기질문: Sumoylation and small ubiquitin-related modifier in Alzheimer disease (sumoylation[tiab] OR SUMO[tiab] OR "small ubiquitin-related modifier"[tiab] OR "small ubiquitin-like modifier"[tiab]) AND ("Alzheimer disease"[tiab] OR "Alzheimer's disease"[tiab] OR Alzheimer*[tiab] OR "Alzheimer disease"[MeSH Terms])

출판 연도

2003: 2편220032006: 1편12007: 1편12008: 2편22009: 1편120102011: 2편22012: 1편12013: 2편22014: 4편42015: 3편320152016: 1편12017: 6편62018: 7편72019: 5편52020: 1편120202021: 3편32022: 6편62023: 5편52024: 3편32025: 11편112026: 3편32026

선별된 70편의 출판 연도. 검색일(2026-10-31) 기준이며, 그 이후 논문은 들어 있지 않습니다.

주제별 논문

주제 이름은 ReviewFast가 초록의 단어로 자동으로 붙인 것입니다. 왼쪽 숫자는 관련도(0–1)입니다. RECODE 는 우리 연구팀 논문입니다.

01expression · gene17편

  1. 0.95

    Melatonin Induction of APP Intracellular Domain 50 SUMOylation Alleviates AD through Enhanced Transcriptional Activation and Abeta Degradation

    Liu YC, Hsu WL, Ma YL et al. · Molecular therapy : the journal of the American Society of Gene Therapy · 2021

  2. 0.94

    SENP1 inhibits aerobic glycolysis in Abeta(1-42)-incubated astrocytes by promoting PUM2 deSUMOylation

    Liu Q, Jiang M, Wang Z et al. · Cell biology and toxicology · 2025

  3. 0.94

    Epigenetic regulation of HDAC1 SUMOylation as an endogenous neuroprotection against Abeta toxicity in a mouse model of Alzheimer's disease

    Tao CC, Hsu WL, Ma YL et al. · Cell death and differentiation · 2017

  4. 0.94

    Age-related p53 SUMOylation accelerates senescence and tau pathology in Alzheimer's disease

    Wan L, Yang F, Yin A et al. · Cell death and differentiation · 2025

  5. 0.94

    p53 SUMOylation promotes neurogenesis defects in APP/PS1 mice

    Yin A, Gui Y, Wan L et al. · Journal of Alzheimer's disease : JAD · 2025

  6. 0.94

    SET SUMOylation promotes its cytoplasmic retention and induces tau pathology and cognitive impairments

    Qin M, Li H, Bao J et al. · Acta neuropathologica communications · 2019

  7. 0.94

    PIAS1-mediated GSK3beta SUMOylation exacerbates tauopathy and cognitive deficits in Alzheimer's disease models

    Qiu Y, Wu S, Zhong Y et al. · Molecular psychiatry · 2026

  8. 0.93

    Polymorphisms of small ubiquitin-related modifier genes are associated with risk of Alzheimer's disease in Korean: A case-control study 이 논문

    Mun MJ, Kim JH, Choi JY et al. · Journal of the neurological sciences · 2016

  9. 0.93

    Protein inhibitor of activated STAT1 Ser(503) phosphorylation-mediated Elk-1 SUMOylation promotes neuronal survival in APP/PS1 mice

    Liu SY, Ma YL, Hsu WL et al. · British journal of pharmacology · 2019

  10. 0.93

    Exercise-Induced Reduction of IGF1R Sumoylation Attenuates Neuroinflammation in APP/PS1 Transgenic Mice

    Chen Y, Chen X, Luo Z et al. · Journal of advanced research · 2025

  11. 0.92

    Effects of aerobic exercise on hippocampal SUMOylation in APP/PS1 transgenic mice

    Chenfei Z, Haizhen Y, Jie X et al. · Neuroscience letters · 2022

  12. 0.90

    Ubc9 gene polymorphisms and late-onset Alzheimer's disease in the Korean population: a genetic association study

    Ahn K, Song JH, Kim DK et al. · Neuroscience letters · 2009

  13. 0.88

    Identification of small ubiquitin-related modifier (SUMO)-related genes-based biomarkers in Alzheimer's disease based on bioinformatics analysis

    Chen P, Fan M, Lin H et al. · Scientific reports · 2026

  14. 0.82

    Functional genomics study of protein inhibitor of activated STAT1 in mouse hippocampal neuronal cells revealed by RNA sequencing

    He K, Zhang J, Liu J et al. · Aging · 2021

  15. 0.73

    Small molecule SUMOylation activators are novel neuroprotective agents

    Krajnak K, Dahl R · Bioorganic & medicinal chemistry letters · 2018

  16. 0.60

    Genetic Networks of Alzheimer's Disease, Aging, and Longevity in Humans

    Balmorez T, Sakazaki A, Murakami S · International journal of molecular sciences · 2023

  17. 0.58

    Prenatal Exposure to Benzophenone-3 Impairs Autophagy, Disrupts RXRs/PPARgamma Signaling, and Alters Epigenetic and Post-Translational Statuses in Brain Neurons

    Wnuk A, Rzemieniec J, Staron J et al. · Molecular neurobiology · 2019

02amyloid precursor · abeta17편

  1. 0.95

    SUMO1 modulates Abeta generation via BACE1 accumulation

    Yun SM, Cho SJ, Song JC et al. · Neurobiology of aging · 2013

  2. 0.95

    Positive and negative regulation of APP amyloidogenesis by sumoylation

    Li Y, Wang H, Wang S et al. · Proceedings of the National Academy of Sciences of the United States of America · 2003

  3. 0.95

    BACE1 SUMOylation deregulates phosphorylation and ubiquitination in Alzheimer's disease pathology

    Zhao Y, Zhou H, Zhao Y et al. · Journal of neurochemistry · 2023

  4. 0.94

    Genetic and pharmacologic enhancement of SUMO2 conjugation prevents and reverses cognitive impairment and synaptotoxicity in a preclinical model of Alzheimer's disease

    Fioriti L, Wijesekara N, Argyrousi EK et al. · Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025

  5. 0.94

    APP SUMOylation prevents BACE1 cleavage of APP and increases BACE1 degradation to promote the nonamyloidogenic pathway

    Liu YC, Hsu WL, Ma YL et al. · Molecular medicine (Cambridge, Mass.) · 2025

  6. 0.94

    SUMO1 promotes Abeta production via the modulation of autophagy

    Cho SJ, Yun SM, Jo C et al. · Autophagy · 2015

  7. 0.94

    SENP1 and SENP2 regulate SUMOylation of amyloid precursor protein

    Maruyama T, Abe Y, Niikura T · Heliyon · 2018

  8. 0.94

    BACE1 SUMOylation increases its stability and escalates the protease activity in Alzheimer's disease

    Bao J, Qin M, Mahaman YAR et al. · Proceedings of the National Academy of Sciences of the United States of America · 2018

  9. 0.93

    SUMO-2 activity is inhibited by non-covalent interactions with the Abeta peptide: an exploration of potential pathogenic mechanisms in Alzheimer's disease

    Ciaffaglione V, Grasso G, Lanza V et al. · International journal of biological macromolecules · 2025

  10. 0.92

    SUMO1 impact on Alzheimer disease pathology in an amyloid-depositing mouse model

    Knock E, Matsuzaki S, Takamura H et al. · Neurobiology of disease · 2018

  11. 0.92

    Sumoylation of amyloid precursor protein negatively regulates Abeta aggregate levels

    Zhang YQ, Sarge KD · Biochemical and biophysical research communications · 2008

  12. 0.92

    Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins

    Dorval V, Mazzella MJ, Mathews PM et al. · The Biochemical journal · 2007

  13. 0.92

    Plasma SUMO1 Protein is Elevated in Alzheimer's Disease

    Cho SJ, Yun SM, Lee Dh et al. · Journal of Alzheimer's disease : JAD · 2015

  14. 0.85

    Genetic deletion of TNFRII gene enhances the Alzheimer-like pathology in an APP transgenic mouse model via reduction of phosphorylated IkappaBalpha

    Jiang H, He P, Xie J et al. · Human molecular genetics · 2014

  15. 0.84

    Deciphering the endogenous SUMO-1 landscape: a novel combinatorial peptide enrichment strategy for global profiling and disease association

    Zhang X, Zhong B, Sun Y et al. · Chemical science · 2025

  16. 0.82

    A new wrestler in the battle between alpha- and beta-secretases for cleavage of APP

    Neve RL · Trends in neurosciences · 2003

  17. 0.65

    Structure-activity relationships for flavone interactions with amyloid beta reveal a novel anti-aggregatory and neuroprotective effect of 2',3',4'-trihydroxyflavone (2-D08)

    Marsh DT, Das S, Ridell J et al. · Bioorganic & medicinal chemistry · 2017

03underlying · ubc915편

  1. 0.95

    Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease

    Lee L, Dale E, Staniszewski A et al. · Scientific reports · 2014

  2. 0.95

    Effects of amyloid-beta on protein SUMOylation and levels of mitochondrial proteins in primary cortical neurons

    Soares ES, de Souza ACG, Zanella CA et al. · IBRO neuroscience reports · 2022

  3. 0.95

    Targeting SUMO-1ylation Contrasts Synaptic Dysfunction in a Mouse Model of Alzheimer's Disease

    Marcelli S, Ficulle E, Iannuzzi F et al. · Molecular neurobiology · 2017

  4. 0.94

    High Fat Diet Mediates Amyloid-beta Cleaving Enzyme 1 Phosphorylation and SUMOylation, Enhancing Cognitive Impairment in APP/PS1 Mice

    Bao J, Liang Z, Gong X et al. · Journal of Alzheimer's disease : JAD · 2022

  5. 0.94

    Age-related changes of protein SUMOylation balance in the AbetaPP Tg2576 mouse model of Alzheimer's disease

    Nistico R, Ferraina C, Marconi V et al. · Frontiers in pharmacology · 2014

  6. 0.94

    Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model

    McMillan LE, Brown JT, Henley JM et al. · Neuroscience letters · 2011

  7. 0.93

    Reduced SUMOylation of Nrf2 signaling contributes to its inhibition induced by amyloid-beta

    Wang P, Wang X, Qiao K et al. · Neuroscience letters · 2023

  8. 0.92

    Alteration of global protein SUMOylation in neurons and astrocytes in response to Alzheimer's disease-associated insults

    Maruyama T, Wada H, Abe Y et al. · Biochemical and biophysical research communications · 2018

  9. 0.92

    SUMO-1 conjugation blocks beta-amyloid-induced astrocyte reactivity

    Hoppe JB, Rattray M, Tu H et al. · Neuroscience letters · 2013

  10. 0.91

    Estrogen Modulates ubc9 Expression and Synaptic Redistribution in the Brain of APP/PS1 Mice and Cortical Neurons

    Lai YJ, Liu L, Hu XT et al. · Journal of molecular neuroscience : MN · 2017

  11. 0.90

    Abeta-induced presynaptic release of UBC9 through extracellular vesicles involves SNAP23

    Long Y, Cheng Y, Yang J et al. · Neuroscience letters · 2022

  12. 0.87

    CR6-interacting factor 1 is a key regulator in Abeta-induced mitochondrial disruption and pathogenesis of Alzheimer's disease

    Byun J, Son SM, Cha MY et al. · Cell death and differentiation · 2015

  13. 0.82

    Nuclear Translocation of IGF1R Induces Cell Cycle Re-entry via Cyclin D1 Regulation in an Abeta-Driven Alzheimer's Disease Model

    Sengupta P, Mukhopadhyay D · Molecular neurobiology · 2026

  14. 0.81

    Cytoplasmic HDAC4 recovers synaptic function in the 3xTg mouse model of Alzheimer's disease

    Colussi C, Aceto G, Ripoli C et al. · Neuropathology and applied neurobiology · 2023

  15. 0.64

    Free d-aspartate triggers NMDA receptor-dependent cell death in primary cortical neurons and perturbs JNK activation, Tau phosphorylation, and protein SUMOylation in the cerebral cortex of mice lacking d-aspartate oxidase activity

    Nuzzo T, Feligioni M, Cristino L et al. · Experimental neurology · 2019

04tau · aggregation11편

  1. 0.94

    Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathy

    Shui X, Zheng X, Wu J et al. · Molecular neurodegeneration · 2025

  2. 0.94

    SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination

    Luo HB, Xia YY, Shu XJ et al. · Proceedings of the National Academy of Sciences of the United States of America · 2014

  3. 0.90

    SUMO-1 immunoreactivity co-localizes with phospho-Tau in APP transgenic mice but not in mutant Tau transgenic mice

    Takahashi K, Ishida M, Komano H et al. · Neuroscience letters · 2008

  4. 0.90

    SUMO2 rescues neuronal and glial cells from the toxicity of P301L Tau mutant

    Orsini F, Pascente R, Martucci A et al. · Frontiers in cellular neuroscience · 2024

  5. 0.87

    SUMO inhibits Tau aggregation in Alzheimer's disease

    Chinnathambi S, Rangappa N · Advances in protein chemistry and structural biology · 2025

  6. 0.84

    Depleting Trim28 in adult mice is well tolerated and reduces levels of alpha-synuclein and tau

    Rousseaux MW, Revelli JP, Vazquez-Velez GE et al. · eLife · 2018

  7. 0.77

    SARS-CoV-2 Nucleocapsid Protein Induces Tau Pathological Changes That Can Be Counteracted by SUMO2

    Orsini F, Bosica M, Martucci A et al. · International journal of molecular sciences · 2024

  8. 0.61

    SUMO1 Modification of Tau in Progressive Supranuclear Palsy

    Takamura H, Nakayama Y, Ito H et al. · Molecular neurobiology · 2022

  9. 0.60

    Charge neutralization of lysine via carbamylation reveals hidden aggregation hot-spots in tau protein flanking regions

    Gadhavi J, Shah S, Sinha T et al. · The FEBS journal · 2022

  10. 0.60

    A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain

    Ercan-Herbst E, Ehrig J, Schondorf DC et al. · Acta neuropathologica communications · 2019

  11. 0.59

    Mass Spectrometry Analysis of Lysine Posttranslational Modifications of Tau Protein from Alzheimer's Disease Brain

    Thomas SN, Yang AJ · Methods in molecular biology (Clifton, N.J.) · 2017

05system · disorders6편

  1. 0.91

    The pivotal role of SUMO-1-JNK-Tau axis in an in vitro model of oxidative stress counteracted by the protective effect of curcumin

    Buccarello L, Dragotto J, Iorio F et al. · Biochemical pharmacology · 2020

  2. 0.89

    SUMO1 modification of 0N4R-tau is regulated by PIASx, SENP1, SENP2, and TRIM11

    Wada H, Maruyama T, Niikura T · Biochemistry and biophysics reports · 2024

  3. 0.79

    Generation and nuclear translocation of sumoylated transmembrane fragment of cell adhesion molecule L1

    Lutz D, Wolters-Eisfeld G, Joshi G et al. · The Journal of biological chemistry · 2012

  4. 0.68

    SUMO-SIM interactions regulate the activity of RGSZ2 proteins

    Garzon J, Rodriguez-Munoz M, Vicente-Sanchez A et al. · PloS one · 2011

  5. 0.61

    The PML-nuclear inclusion of human supraoptic neurons: a new compartment with SUMO-1- and ubiquitin-proteasome-associated domains

    Villagra NT, Navascues J, Casafont I et al. · Neurobiology of disease · 2006

  6. 0.56

    BARHL1 Is Downregulated in Alzheimer's Disease and May Regulate Cognitive Functions through ESR1 and Multiple Pathways

    Barh D, Garcia-Solano ME, Tiwari S et al. · Genes · 2017

06ubiquitination · neurodegenerative4편

  1. 0.89

    SUMO1-conjugation is altered during normal aging but not by increased amyloid burden

    Stankova T, Piepkorn L, Bayer TA et al. · Aging cell · 2018

  2. 0.88

    The Dynamic SUMOylation Changes and Their Potential Role in the Senescence of APOE4 Mice

    Xu Y, Cai W, Sang S et al. · Biomedicines · 2023

  3. 0.88

    SENP6 Maintains Mitochondrial Homeostasis by Regulating Mitochondrial Protein Import Through deSUMOylation of TOM40

    Hu L, Li J, Guo H et al. · Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025

  4. 0.79

    Computational Analysis Indicates That PARP1 Acts as a Histone Deacetylases Interactor Sharing Common Lysine Residues for Acetylation, Ubiquitination, and SUMOylation in Alzheimer's and Parkinson's Disease

    Gupta R, Kumar P · ACS omega · 2021